These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36358610)
21. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients. Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992 [TBL] [Abstract][Full Text] [Related]
22. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis. Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079 [TBL] [Abstract][Full Text] [Related]
23. Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients. Wu C; Xu B; Zhou Y; Ji M; Zhang D; Jiang J; Wu C Oncotarget; 2016 Dec; 7(52):85876-85887. PubMed ID: 27811377 [TBL] [Abstract][Full Text] [Related]
24. Targeting SLC3A2 subunit of system X Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413 [TBL] [Abstract][Full Text] [Related]
25. Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Dong Y; Li S; Sun X; Wang Y; Lu T; Wo Y; Leng X; Kong D; Jiao W Onco Targets Ther; 2020; 13():11111-11124. PubMed ID: 33149622 [TBL] [Abstract][Full Text] [Related]
26. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y; Wang M; Liu B J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601 [TBL] [Abstract][Full Text] [Related]
27. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123 [TBL] [Abstract][Full Text] [Related]
28. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
29. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma. Ma X; Yang S; Jiang H; Wang Y; Xiang Z J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056 [TBL] [Abstract][Full Text] [Related]
30. The prognostic and immune infiltration role of ITGB superfamily members in non-small cell lung cancer. Wu J; Wang W; Li Z; Ye X Am J Transl Res; 2022; 14(9):6445-6466. PubMed ID: 36247270 [TBL] [Abstract][Full Text] [Related]
31. Integrative bioinformatic analysis of p53 and pathway alterations in two different lung cancer subtypes. Zhang Y; Williams-Villalobo A; Godavarthi JD; Shakoor F; Xiong S; Liu B Biochem Biophys Rep; 2023 Mar; 33():101404. PubMed ID: 36532876 [TBL] [Abstract][Full Text] [Related]
32. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. Yu H; Pang Z; Li G; Gu T J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722 [TBL] [Abstract][Full Text] [Related]
34. Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma. Zhan C; Yan L; Wang L; Sun Y; Wang X; Lin Z; Zhang Y; Shi Y; Jiang W; Wang Q J Thorac Dis; 2015 Aug; 7(8):1398-405. PubMed ID: 26380766 [TBL] [Abstract][Full Text] [Related]
35. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer. Wang J; Yang Q; Tang M; Liu W Front Oncol; 2022; 12():911316. PubMed ID: 35957916 [TBL] [Abstract][Full Text] [Related]
36. Archaea Microbiome Dysregulated Genes and Pathways as Molecular Targets for Lung Adenocarcinoma and Squamous Cell Carcinoma. Uzelac M; Li Y; Chakladar J; Li WT; Ongkeko WM Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232866 [TBL] [Abstract][Full Text] [Related]
37. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer. Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525 [TBL] [Abstract][Full Text] [Related]
38. Gephyrin suppresses lung squamous cell carcinoma development by reducing mTOR pathway activation. Zhang X; Cheng D; Liu Y; Wu Y; He Z Cancer Manag Res; 2019; 11():5333-5341. PubMed ID: 31239782 [No Abstract] [Full Text] [Related]
39. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates. Meng F; Zhang L; Ren Y; Ma Q J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039 [TBL] [Abstract][Full Text] [Related]
40. High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma. Li P; Chen X; Zhou S; Xia X; Wang E; Han R; Zeng D; Fei G; Wang R J Inflamm Res; 2022; 15():4171-4184. PubMed ID: 35912402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]